Motonori Araki's practice includes mergers and acquisitions, commercial transactions, intellectual property licensing, and international dispute resolution, in a variety of industries including, among others, pharmaceuticals and medical equipment. His M&A practice includes the representation of buyers and sellers on cross-border transactions and covers structuring, documenting, and negotiating transactions. He also has an active life science practice, representing major U.S. and Japanese pharmaceutical companies in cross-border transactions and regulatory matters.
Mr. Araki represents major Japanese industrial, trading and service companies in their dealings in and with other Asian countries and the United States. He has substantial experience in representing Japanese corporations in U.S. intellectual property litigation, U.S. antitrust litigation, and other dispute resolution. In these representations, he counsels Japanese corporations for litigation strategies, efficient discovery, effective pleadings, and settlement negotiations. As part of his dispute resolution practice, Mr. Araki also handled the first comprehensive anti-dumping case in Japan.
Mr. Araki is a member of the Japan Federation of Bar Associations and the Daiichi Tokyo Bar Association. He is fluent in English in addition to his native Japanese.